Quality Investor
About 

Seneca Foods Corporation PFD $12.00

Rank #436Op. Leverage

SENEM · OTC

Seneca Foods Corporation PFD $12.00 (SENEM) — Rank #436 by gross profitability (GP/assets 0.12) · ROE 5.3% · Piotroski F-Score 7 / 9.

As-of 2026-09-15 · CIK 0000088948 · all metrics point-in-time as of the filing date.

About

State
NY
Filer Category
Accelerated filer
Fiscal Year End
March 31

Price History

SENEM+394.4% · +37.7% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

30.2

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

—

Industry

—

Exchange

OTC

Signal Flags

2 green2 yellow
Revenue growth acceleratingGrowth rate increasing year over year
Operating leverage expandingOperating income growing faster than revenue
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why

Quality Profile

Profitability

1/1 pass
GP / assets
0.12
Return on equity
5.3%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.63
Current ratio
3.77×
Net cash
-$130.18M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.0%

Growth

1/2 pass
Revenue growth
25.1%
Piotroski F-Score
7 / 9
Share dilution
70724.0%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

-15.1%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 70724.0% — per-share value needs a total required return of 70709.0% once share-count change is priced in.

vs. own 6-year median revenue growth: 4.2%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

-17.9%

r = 10% (base)

-15.1%

r = 12%

-12.6%

Net debt / market cap: 10.5%

Base FCF: $298.3M3Y mean FCF: -$45.9M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

N/A
5.0xmed 16.3x25.9x

P / S

Price / revenue per share

0.0xCheap
0.0xmed 0.0x0.3x

P / B

Price / book value per share

0.0xCheap
0.0xmed 0.0x1.0x

P / GP

Price / gross profit per share

0.0xFair
0.0xmed 0.0x3.8x

Operating margin expansion and free cash flow are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.12

Primary signal (Novy-Marx).

15th of 18 SIC 20 peers

Return on equity

5.3%

Gross margin

9.5%

15th of 18 SIC 20 peers

Revenue growth (YoY)

25.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2014201620172018
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

—

Revenue CAGR (5Y)

—

Earnings CAGR (3Y)

-3.7%

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.63

8th of 18 SIC 20 peers (best = lowest)

Current ratio

3.77×

3rd of 18 SIC 20 peers

Quick ratio

0.85×

Net cash

-$130.18M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$298.25M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

6.23

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.0%

Stock-based comp intensity.

Dividend safety

Composite score

3.0 / 5

Good
Payout ratio
0.1%5/5 Strong
FCF coverage
12967.39×5/5 Strong
Dividend growth streak
0 yr0/5 Weak
Balance-sheet health
D/E 0.63 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

7 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20122018
Capital Return
Value
Startup
View full financial statements →